[Efffect of baicalin on antipyresis and influence on cytokine]

Qiannan Li1, Xiaoqun Ge

  • 1Department of Pharmacology, Medical School of Yangzhou University, Yangzhou 225001, China. lqngg@126.com

Abstract

Insights

Baicalin demonstrates significant antipyretic effects in rats by reducing fever and lowering inflammatory cytokines, specifically Interleukin-1 beta (IL-1beta) and Tumor Necrosis Factor-alpha (TNF-alpha). This suggests a potential therapeutic role for baicalin in managing fever.

Area of Science:

  • Pharmacology
  • Immunology
  • Neuroscience

Context:

  • Fever is a common symptom of inflammation.
  • Yeast-induced fever in rats is a standard model for studying antipyretic agents.
  • Inflammatory cytokines play a crucial role in the fever response.

Purpose:

  • To investigate the antipyretic efficacy of baicalin.
  • To assess baicalin's impact on key inflammatory cytokines (IL-6, IL-1beta, TNF-alpha).
  • To elucidate the mechanism underlying baicalin's fever-reducing action.

Summary:

  • Baicalin administration significantly reduced yeast-induced fever in rats.
  • Baicalin decreased levels of IL-6, IL-1beta, and TNF-alpha in serum, hypothalamus, and cerebrospinal fluid (CSF).
  • A direct correlation was observed between baicalin's fever-reducing effect and its ability to lower IL-1beta and TNF-alpha levels.

Impact:

  • Baicalin exhibits notable antipyretic properties.
  • The findings suggest baicalin's therapeutic potential in fever management.
  • Baicalin's mechanism involves the modulation of inflammatory cytokine production.